Lau GKK, Yiu HHY,
Fong DYT, Cheng HC, Au WY, Lai LSF, Cheung M, Zhang HY, Lie
A, Ngan R, Liang R. “Early” is superior to
“deferred” pre-umptive lamivudine therapy for
hepatitis B patients undergoing chemotherapy. Gastroenterology,
125: 1742 – 1749, 2003.
Au WY, Gascoyne
RD, Klasa RD, Connors JM, Gallagher RP, Le ND, Loong F, Law
CK, Liang R. Incidence and spectrum of non-Hodgkin lymphoma
in Chinese migrants to British Columbia. British Journal
of Haematology, 128: 792 – 796, 2005.
Hui CK, Lei AKW,
Au WY, Leung AYH, Ma SY, Cheung WWW, Zhang HY, Chim CS, Kwong
YL, Liang R Lau GKK. A long-term follow-up study on hepatitis
B surface antigen positive patients undergoing allogeneic
hematopoietic cell transplantation. Blood, 106: 464 –
Au WY, Weisenburger
D, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J,
Armitage JO, and Liang R. Clinical differences between
nasal and extranasal NK/T-cell lymphoma: a study of 136 cases
from the International Peripheral T-cell Lymphoma Project.
Blood, 113: 3931 – 3937, 2009.
Liang R. How
I treat and monitor viral hepatitis B infection in patients
receiving intensive immunosuppressive therapies or undergoing
hematopoietic stem cell transplantation. Blood, 113:
Liang R. Advances
in the management and monitoring of extranodal NK/T-cell lymphoma,
nasal type. British Journal of Haematology, in press.